Bunka, Mary http://orcid.org/0000-0002-7963-0667
Ghanbarian, Shahzad
Riches, Linda
Landry, Ginny
Edwards, Louisa
Hoens, Alison M.
Bryan, Stirling
Funding for this research was provided by:
Genome British Columbia (B26PMH)
Genome Canada (B26PMH)
Michael Smith Foundation for Health Research (18932)
Article History
Accepted: 7 July 2022
First Online: 25 July 2022
Declarations
:
: The Pharmacogenomics for Depression Project was funded by Genome BC, Genome Canada, and Michael Smith Health Research BC. Funding was provided by Genome British Columbia, B26PMH. Genome Canada, B26PMH. Michael Smith Health Research BC, 18932.
: Mary Bunka, Shahzad Ghanbarian, Linda Riches, Ginny Landry, Louisa Edwards, Alison M. Hoens, and Stirling Bryan have no conflicts of interest that are directly relevant to the content of this article.
: Not applicable.
: Not applicable.
: Not applicable.
: Data sharing is not applicable to this article as no datasets were generated or analyzed.
: Not applicable.
: All authors shaped the idea for the manuscript. The first draft of the manuscript was written by MB except as noted in the text and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.